Interrelationship between angiotensin and vascular alpha adrenergic receptors.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001808:Blood Vessels / Q000187:drug effects; D004357:Drug Synergism; D008680:Metaraminol / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug; D012110:Reserpine / Q000494:pharmacology; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects; D013566:Sympathomimetics / Q000494:pharmacology*; D014667:Vasopressins / Q000494:pharmacology
D011759:Pyrrolidines; D011955:Receptors, Drug; D013566:Sympathomimetics; D010643:Phenoxybenzamine; D014667:Vasopressins; D000804:Angiotensin II; D010656:Phenylephrine; D008680:Metaraminol; D012110:Reserpine; D009638:Norepinephrine